Olivier Loeillot, Chief Executive Officer at REPLIGEN CORP (RGEN), sold 7,041 shares at $170.00 ($1.2M) on 2025-11-25, disclosed to the SEC on 2025-11-26.
Scheduled sale ($1.2M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RGEN | SELL | 2026-09-22 | $977K | — | Filing → |
| RGEN | SELL | 2026-09-08 | $504K | — | Filing → |
| RGEN | SELL | 2026-08-21 | $977K | — | Filing → |